compound 41 [PMID: 31855425]   Click here for help

GtoPdb Ligand ID: 10598

PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 41 is a structurally novel, potent, selective and orally bioavailable PI3Kδ inhibitor [1]. Results from this inhibitor optimisation study suggest that off-target inhibition of Vps34 is associated with in vivo toxicity in a rat PK model.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 1
Rotatable bonds 11
Topological polar surface area 126.06
Molecular weight 535.2
XLogP 0.78
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COCCS(=O)(=O)Nc1cc(cnc1OC)c1cc(OCC2OCCN(C2)C2COC2)c2c(c1)COC2
Isomeric SMILES COCCS(=O)(=O)Nc1cc(cnc1OC)c1cc(OC[C@@H]2OCCN(C2)C2COC2)c2c(c1)COC2
InChI InChI=1S/C25H33N3O8S/c1-31-5-6-37(29,30)27-23-8-18(10-26-25(23)32-2)17-7-19-12-33-16-22(19)24(9-17)36-15-21-11-28(3-4-35-21)20-13-34-14-20/h7-10,20-21,27H,3-6,11-16H2,1-2H3/t21-/m1/s1
InChI Key ZWPJBXLFZFLGMV-OAQYLSRUSA-N
Bioactivity Comments
Compared to other inhibitors in the study (e.g. 19), 41 has lower toxicity and an acceptable pharmacokinetic profile for oral dosing, along with good primary activity and an enhanced selectivity profile [1]. Using the lipid kinobead assay 41 was determined to bind >600-fold more potently to PI3Kδ than to the other class I PI3Ks, and >200-fold more potently to PI3Kδ than to Vps34 (a class III PI3K enzyme).
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta Hs Inhibitor Inhibition 9.7 pKd - 1
pKd 9.7 (Kd 2x10-10 M) [1]
Description: Apparent binding affinity determined using the lipid kinobead assay.
phosphatidylinositol 3-kinase catalytic subunit type 3 Hs Inhibitor Inhibition 7.2 pKd - 1
pKd 7.2 (Kd 6.31x10-8 M) [1]
Description: Apparent binding affinity determined using the lipid kinobead assay.
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta Hs Inhibitor Inhibition 8.2 pIC50 - 1
pIC50 8.2 (IC50 6.31x10-9 M) [1]
phosphatidylinositol 3-kinase catalytic subunit type 3 Hs Inhibitor Inhibition 7.2 pIC50 - 1
pIC50 7.2 (IC50 6.31x10-8 M) [1]
Description: Determined in a chemoproteomic competition binding assay with antibody-based readout.
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma Hs Inhibitor Inhibition 6.5 pIC50 - 1
pIC50 6.5 (IC50 3.16x10-7 M) [1]
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Hs Inhibitor Inhibition 5.8 pIC50 - 1
pIC50 5.8 (IC50 1.585x10-6 M) [1]
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta Hs Inhibitor Inhibition 5.7 pIC50 - 1
pIC50 5.7 (IC50 1.995x10-6 M) [1]